News

Queen Mary University of London1h
New combination treatment could extend the lifetime of people with amyotrophic lateral sclerosis (ALS)
The results of the MIROCALS randomised clinical trial showed that adding low-dose interleukin-2 (IL2LD) to standard treatment ...
Queen Mary University of London1h
New study sheds light on health differences between sexes
The results of an international study led by researchers from Queen Mary University of London’s Precision Healthcare ...